Remynd logo
VerifiedBiotechnology· Founded 2002

Remynd

Remynd is a clinical-stage biotechnology company dedicated to developing first-in-class oral therapeutics for neurodegenerative diseases, including Alzheimer’s disease and Huntington’s disease. By targeting the underlying disease mechanisms, reMYND aims to restore neuronal function and slow disease progression. With a strong commitment to innovation and patient impact, the company advances breakthrough therapies from discovery to clinical development.

7-day free trial · no credit card

HeadquartersHeverlee, BelgiumEmployees33(11 to 50)Founded year2002Websiteremynd.comLinkedIn profileLinkedIn

Verified contacts

26

available on Kipplo

LinkedIn employees

33

11 to 50 range

Open roles

no listings

Distinct roles

19

indexed titles

Tech stack

2

tools in use

Monthly traffic

25

organic / mo

Sign up free to see all 26 verified contacts at Remynd

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

26 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Remynd

19 distinct titles indexed · top 10 shown.

  • 2cro study director
  • 2scientist
  • 1()
  • 1associate scientist
  • 1cbo
  • 1chief scientific officer
  • 1clinical operations associate
  • 1direct support staff
  • 1expert research associate
  • 1head of discovery
  • +9more titles

Sign up to unlock all 26 contacts at Remynd

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 26 verified contacts at Remynd

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Remynd | Kipplo Discover